Healthcare/Hospital Law
Jan. 7, 2004
FDA's Ephedra Ban Likely Will Spark Legal Challenges
WASHINGTON - Though Food and Drug Administration officials said last week that their decision to ban ephedra was the culmination of a thorough evaluation of the effects of the herbal supplement, a controversial 1994 law governing the dietary-supplement market may result in intense legal scrutiny of the agency's decision before it is finalized.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In